p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis
- PMID: 1644659
- PMCID: PMC5918882
- DOI: 10.1111/j.1349-7006.1992.tb00125.x
p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis
Abstract
Mutations of the p53 gene play an important role in the development of common human malignancies. We investigated mutations of this gene in 26 surgical specimens of esophageal cancer using the polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis. The results were correlated with histological findings, DNA ploidy and the short-term relapse of the disease. PCR-SSCP analysis detected mutations of the p53 gene in 10 tumors (38%), eight in exons 5-6 and two in exons 7-8. A higher incidence of lymph node metastasis, poorly differentiated tumor, DNA aneuploidy and short-term relapse of the disease was observed in cases with p53 gene mutations, although the findings were not statistically significant.
Similar articles
-
Sensitive detection of p53 gene mutations in esophageal endoscopic biopsy specimens by cell sorting combined with polymerase chain reaction single-strand conformation polymorphism analysis.Jpn J Cancer Res. 1992 Dec;83(12):1253-6. doi: 10.1111/j.1349-7006.1992.tb02754.x. Jpn J Cancer Res. 1992. PMID: 1483940 Free PMC article.
-
p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.Mod Pathol. 2001 May;14(5):397-403. doi: 10.1038/modpathol.3880324. Mod Pathol. 2001. PMID: 11353048
-
p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.Cancer Epidemiol Biomarkers Prev. 1996 Apr;5(4):277-84. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8722219
-
p53 gene alternation in squamous cell carcinoma of the esophagus detected by PCR-cold SSCP analysis.Proc Natl Sci Counc Repub China B. 1998 Jul;22(3):114-21. Proc Natl Sci Counc Repub China B. 1998. PMID: 9779600
-
p53 and human cancer: the first ten thousand mutations.Adv Cancer Res. 2000;77:81-137. doi: 10.1016/s0065-230x(08)60785-x. Adv Cancer Res. 2000. PMID: 10549356 Review. No abstract available.
Cited by
-
Multimodality treatment of cancer arising from Barrett's epithelium.World J Surg. 1995 Mar-Apr;19(2):205-9. doi: 10.1007/BF00308627. World J Surg. 1995. PMID: 7754624 Review.
-
Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma.Virchows Arch A Pathol Anat Histopathol. 1993;422(4):271-6. doi: 10.1007/BF01608335. Virchows Arch A Pathol Anat Histopathol. 1993. PMID: 8506620
-
Sensitive detection of p53 gene mutations in esophageal endoscopic biopsy specimens by cell sorting combined with polymerase chain reaction single-strand conformation polymorphism analysis.Jpn J Cancer Res. 1992 Dec;83(12):1253-6. doi: 10.1111/j.1349-7006.1992.tb02754.x. Jpn J Cancer Res. 1992. PMID: 1483940 Free PMC article.
-
Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment.Ann Surg Oncol. 1994 Jan;1(1):79-86. doi: 10.1007/BF02303545. Ann Surg Oncol. 1994. PMID: 7834433 Review.
-
International cancer seminars: a focus on esophageal squamous cell carcinoma.Ann Oncol. 2017 Sep 1;28(9):2086-2093. doi: 10.1093/annonc/mdx279. Ann Oncol. 2017. PMID: 28911061 Free PMC article. Review.
References
-
- ) Tsuda , T. , Tahara , E. , Kajiyama , G. , Sakamoto , H. , Terada , M. and Sugimura , T.High incidence of co‐amplification of hst‐1 and int‐2 genes in human esophageal carcinomas . Cancer Res. , 49 , 5505 – 5508 ( 1989. ). - PubMed
-
- ) Kitagawa , Y. , Ueda , M. , Ando , N. , Shinozawa , Y. , Shimizu , N. and Abe , O.Significance of int‐2hst‐1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma . Cancer Res. , 51 , 1504 – 1508 ( 1991. ). - PubMed
-
- ) Lu , S. H. , Hsieh , L. L. , Luo , F. C. and Weinstein , I. B.Amplification of the EGF receptor and c‐myc genes in human esophageal cancers . Int. J. Cancer , 42 , 502 – 505 ( 1988. ). - PubMed
-
- ) Finlay , C. A. , Hinds , P. W. and Levine , A. J.The p53 protooncogene can act as a suppressor of transformation . Cell , 57 , 1083 – 1093 ( 1990. ). - PubMed
-
- ) Nigro , J. M. , Baker , S. J. , Preisinger , A. C. , Jessup , J. M. , Hostetter , R. , Cleary , K. , Binger , S. H. , Davidson , N. , Baylin , S. , Devilee , P. , Glover , T. , Collins , F. S. , Weston , A. , Modali , R. , Harris , C. C. and Vogelstein , B.Mutations in the p53 gene occur in diverse human tumor types . Nature , 342 , 705 – 708 ( 1989. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous